Mitsuhiro Sato
Direttore operativo presso Fujifilm Kyowa Kirin Biologics Co., Ltd.
Provenienza dei contatti di primo grado di Mitsuhiro Sato
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
Centus Biotherapeutics Ltd.
 Centus Biotherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Centus Biotherapeutics Ltd. is a British company that develops and manufactures biologic products. The joint venture company is based in Cambridge, UK. The company was founded in 2015.
3
| Joint Venture | Pharmaceuticals: Major | 3 |
Fujifilm Kyowa Kirin Biologics Co., Ltd.
 Fujifilm Kyowa Kirin Biologics Co., Ltd. BiotechnologyHealth Technology Fujifilm Kyowa Kirin Biologics Co., Ltd. develops and produces biopharmaceutical products and drugs. The joint venture company is based in Tokyo, Japan. It was founded in 2012, and the CEO is Yoshifumi Torii.
2
| Joint Venture | Biotechnology | 2 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Mitsuhiro Sato tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| NEXIMMUNE, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
CooperVision, Inc.
 CooperVision, Inc. Medical SpecialtiesHealth Technology CooperVision, Inc. engages in the manufacture of contact lenses. It offers monthly, two-week and daily disposable contact lenses, all featuring advanced materials and optics. The firm’s products include MyDay; clariti 1day , Biofinity , Proclear and Avaira family. The company was founded in 1950 and is headquartered in Victor, NY. | Medical Specialties | Corporate Officer/Principal | |
AstraZeneca, Inc.
 AstraZeneca, Inc. BiotechnologyHealth Technology Part of AstraZeneca PLC, AstraZeneca, Inc. manufactures vaccines. | Biotechnology | Corporate Officer/Principal | |
| KYOWA KIRIN CO. LTD. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| Harvard Business School | College/University | Masters Business Admin | |
| Harvard College | College/University | Undergraduate Degree | |
Corvidia Therapeutics, Inc.
 Corvidia Therapeutics, Inc. BiotechnologyHealth Technology Corvidia Therapeutics, Inc. is a biotechnology company focusing on cardiovascular therapies. It develops treatments for atherosclerotic cardiovascular disease, inflammation in chronic kidney diseases, and high triglyceride-induced acute pancreatitis. The company was founded by Michael H. Davidson, Rahul Kakkar, Matt Devalaraja, and Ram Aiyar in 2015 and is headquartered in Waltham, MA. | Biotechnology | Director/Board Member | |
Archigen Biotech Ltd.
 Archigen Biotech Ltd. Pharmaceuticals: MajorHealth Technology Archigen Biotech Ltd. is a British company that develops, manufactures, and distributes biological pharmaceuticals. Archigen Biotech is based in Cambridge, UK. The joint venture company was founded in 2014. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| IMMUNOCORE HOLDINGS PLC | Biotechnology | Chief Operating Officer |
Statistiche
Distribuzione geografica
| Stati Uniti | 7 |
| Regno Unito | 3 |
| Giappone | 2 |
Settori
| Health Technology | 8 |
| Consumer Services | 3 |
Posizioni
| Director/Board Member | 8 |
| Corporate Officer/Principal | 3 |
| Chief Executive Officer | 1 |
| President | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
Contatti più connessi
| Insiders | |
|---|---|
| John Trainer | 8 |
| Yoshifumi Torii | 3 |
| Alex Wilkes | 3 |
| Karl David Bradshaw | 2 |
- Borsa valori
- Insiders
- Mitsuhiro Sato
- Connessioni Società
